Bridged compounds of Formula (I) and Formula (II), pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with MGL modulation, such as those associated with pain, psychiatric disorders, neurological disorders (including, but not limited to major depressive disorder, treatment resistant depression, anxious depression, bipolar disorder), cancers and eye conditions.
wherein R
2
, R
3
R
4
, R
5
and R
6
are defined herein.
Transmission d'un effet stérique péri à travers un noyau hétéroaromatique—II
作者:G. Maury、C. Pigiere
DOI:10.1016/s0040-4020(01)97720-8
日期:1981.1
The quantitative nucleophilic reactivity of alkyl and dialkylimidazo [1,2-a] pyridines towards methyl iodide is described. In the series of monomethyl derivatives the 7-methyl compound is the most activated and the 8-methyl compound the most deactivated. The effects of two alkyl substituants on the rate of alkylation are additive in the absence of intramolecular steric interaction. On the contrary a